← Open Payments lookup

LAURA PRIEST: Open Payments

NPI 1588308134 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,910 in 100 payments from 15 companies in 2025. Trend: 2023 $1,475 · 2024 $1,297 · 2025 $1,910

Food & beverage: $1,910
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.20$371
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$354
ABBVIE INC.14$247
Otsuka America Pharmaceutical, Inc.11$160
Neurocrine BioSciences, Inc.9$150
Alkermes, Inc.7$145
Vanda Pharmaceuticals Inc.6$113
Lundbeck LLC5$101
Supernus Pharmaceuticals, Inc.3$64
Luye Pharma (USA) Ltd.2$52

Products named: CAPLYTA, AUSTEDO XR, VRAYLAR, REXULTI, INGREZZA, ARISTADA, UZEDY, FANAPT.

Industry payments across GA — which companies pay providers there.